Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Background

Dr. Sarah M. Cork is an Associate in the litigation group of Fish & Richardson’s Washington D.C. office. Her practice focuses primarily on patent litigation in the life sciences, including small-molecule and biologic pharmaceuticals, and biomedical devices.

Dr. Cork maintains an active pro bono practice with the goal of obtaining improved housing conditions for low-income individuals. As a student attorney in the University of Michigan Pediatric Advocacy Clinic, she represented pro bono clients in a variety of family law matters, and she gained significant experience with disability law concerns as an intern in the chambers of the Hon. Anthony E. Porcelli (M.D. Florida).

Before attending law school, Dr. Cork earned a Ph.D. in Neuroscience. Her dissertation research evaluated novel anti-angiogenic proteolytic and cell signaling mechanisms as therapeutic targets for glioblastoma multiforme. At Michigan, she taught multiple semesters as a graduate student instructor for an undergraduate Cell Biology capstone course. Dr. Cork also volunteers with the Rare Genomics Institute, a non-profit organization devoted to supporting individuals with rare genetic diseases.

Education

J.D., University of Michigan 2014
​Editor in Chief, ​Michigan Telecommunications and Technology Law Review​
​cum laude


Ph.D., Emory University 2011
Neuroscience


B.S., Duke University 2005
Biology; Biological Anthropology and Anatomy
​with distinction 

Admissions

  • U.S. District Court for the Eastern District of Texas
  • Georgia 2014
  • District of Columbia

Memberships & Affiliations

​Giles S. Rich Inn of Court

Other Distinctions

Selected Publications

An End-Run Around Myriad And ‘Product Of Nature’ Problem,” Law360, Co-authored with Janis Fraser (September 2016).

S.M. Cork et al., A furin/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1, ONCOGENE 31(50):5144-52 (2012).​

S.M. Cork & Erwin G. Van Meir, Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature and tumor development, JOURNAL OF MOLECULAR MEDICINE. 89(8):743–52 (2011).

B. Kaur, S.M. Cork, et al. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism, CANCER RESEARCH 69(3):1212–20 (2009).​

What's trending with Sarah